FDA Inspection 1210183 — Bahadir USA LLC

Bahadir USA LLC — FEI 3005741909

The FDA completed an inspection of Bahadir USA LLC on July 17, 2023 in Carneys Point, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 17, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Carneys Point, NJ (United States)

Citations

IDCFRDescription
316021 CFR 820.184Lack of or inadequate DHR procedures
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures